Breast Lesion Localization Market Report: Trends, Forecast and Competitive Analysis to 2030
상품코드:1417529
리서치사:Lucintel
발행일:2024년 01월
페이지 정보:영문 150 - page report
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
유방 병변 위치특정 동향 및 예측
세계 유방 병변 위치특정 시장은 2024년부터 2030년까지 7.1%의 연평균 복합 성장률(CAGR)로 2030년까지 약 4억 5,300만 달러에 달할 것으로 예측됩니다. 이 시장의 주요 촉진요인은 유방암 조기 발견에 대한 지식 증가, 유방암 수술 건수 증가, 정확하고 최소 침습적인 수술에 대한 수요 증가입니다. 세계 유방 병변 위치특정 시장의 미래는 병원 및 클리닉, 영상 진단센터, 외래수술센터(ASC) 시장에서의 기회로 인해 유망합니다.
유방 병변 위치특정 시장 인사이트
Lucintel의 예측에 따르면, 조기 유방암 발견이 증가하고 덜 침습적인 방법으로의 전환이 진행됨에 따라 유방 보존 요법은 예측 기간 동안 높은 성장을 보일 것으로 예상됩니다.
아시아태평양은 병원 수 증가, 의료비 지출 증가, 환자 수 증가, 의료 서비스에 대한 수요 증가로 인해 예측 기간 동안 가장 높은 성장률을 보일 것으로 예상됩니다.
자주 묻는 질문
Q1. 시장 규모는?
A1. 세계 유방 병변 위치특정 시장은 2030년까지 약 4억 5,300만 달러에 달할 것으로 예상됩니다.
Q2. 시장 성장 전망은?
A2. 세계 유방 병변 위치특정 시장은 2024년부터 2030년까지 연평균 7.1%의 성장률을 나타낼 것으로 예상됩니다.
Q3. 시장 성장에 영향을 미치는 주요 촉진요인은 무엇인가?
A3.이 시장의 주요 촉진요인은 유방암 조기 발견에 대한 지식 증가, 유방암 수술 건수 증가, 정확하고 최소 침습적인 수술에 대한 수요 증가입니다.
Q4. 시장의 주요 부문은?
A4. 세계 유방 병변 위치특정 시장의 미래는 병원 및 클리닉, 영상 진단센터, 외래수술센터(ASC) 시장에서 유망한 기회가 있습니다.
Q5. 시장의 주요 기업은?
A5.유방 병변 위치특정 주요 기업은 다음과 같습니다.
GE Healthcare
Dragerwerk
Koninklijke Philips
Ambu AS
Medline Industrie
Q6. 향후 가장 큰 시장 부문은?
A6.Lucintel의 예측에 따르면, 조기 유방암 발견이 증가하고 덜 침습적인 방법으로의 전환이 진행됨에 따라 유방 보존술은 예측 기간 동안 높은 성장세를 보일 것으로 예상됩니다.
Q7. 향후 5년간 가장 큰 시장으로 성장할 것으로 예상되는 지역은?
A7. 아시아태평양은 병원 수 증가와 의료비 지출 증가, 환자 수 증가, 의료 서비스에 대한 수요 증가로 인해 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.
Q8. 보고서 커스터마이징이 가능한가?
A8. 네. Lucintel은 추가 비용없이 10%의 사용자 정의를 제공합니다.
목차
제1장 주요 요약
제2장 세계의 유방 병변 위치특정 시장 : 시장 역학
서론, 배경, 분류
공급망
업계 촉진요인과 과제
제3장 시장 동향과 예측 분석(2018-2030년)
거시경제 동향(2018-2023년)과 예측(2024-2030년)
세계의 유방 병변 위치특정 시장 동향(2018-2023년)과 예측(2024-2030년)
유형별 세계의 유방 병변 위치특정 시장
와이어 위치특정
방사성 동위 원소 위치특정
자기 위치특정
전자 위치특정
기타
용도별 세계의 유방 병변 위치특정 시장
유방 생검
유방 온존
최종 용도별 세계의 유방 병변 위치특정 시장
병원 및 클리닉
영상 진단센터
외래수술센터(ASC)
기타
제4장 지역별 시장 동향과 예측 분석(2018-2023년)
지역별 세계의 유방 병변 위치특정 시장
북미의 유방 병변 위치특정 시장
유럽의 유방 병변 위치특정 시장
아시아태평양의 유방 병변 위치특정 시장
기타 지역의 유방 병변 위치특정 시장
제5장 경쟁 분석
제품 포트폴리오 분석
운영상 통합
Porter의 Five Forces 분석
제6장 성장 기회와 전략적 분석
성장 기회 분석
유형별 세계의 유방 병변 위치특정 시장 성장 기회
용도별 세계의 유방 병변 위치특정 시장 성장 기회
최종 용도별 세계의 유방 병변 위치특정 시장 성장 기회
지역별 세계의 유방 병변 위치특정 시장 성장 기회
세계 유방 병변 위치특정 시장의 새로운 동향
전략적 분석
신제품 개발
세계의 유방 병변 위치특정 시장 능력 확대
세계 유방 병변 위치특정 시장에서의 인수합병(M&A) 및 합작투자(JV)
인증 및 라이선싱
제7장 유력 기업 개요
GE Healthcare
Dragerwerk
Koninklijke Philips
Ambu AS
Medline Industrie
LSH
영문 목차
영문목차
Breast Lesion Localization Trends and Forecast
The future of the global breast lesion localization market looks promising with opportunities in the hospital & clinic, diagnostic imaging center, and ambulatory surgical center markets. The global breast lesion localization market is expected to reach an estimated $453 million by 2030 with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are increased knowledge of early breast cancer detection, rise in the number of breast cancer surgeries, as well as, growing need for accurate and minimally invasive surgeries.
A more than 150-page report is developed to help in your business decisions.
Breast Lesion Localization by Segment
The study includes a forecast for the global breast lesion localization by type, usage, end use, and region.
Breast Lesion Localization Market by Type [Shipment Analysis by Value from 2018 to 2030]:
Wire Localization
Radioisotope Localization
Magnetic Localization
Electromagnetic Localization
Others
Breast Lesion Localization Market by Usage [Shipment Analysis by Value from 2018 to 2030]:
Breast Biopsy
Breast Conservation
Breast Lesion Localization Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
Hospitals & Clinics
Diagnostic Imaging Centers
Ambulatory Surgical Centers
Others
Breast Lesion Localization Market by Region [Shipment Analysis by Value from 2018 to 2030]:
North America
Europe
Asia Pacific
The Rest of the World
List of Breast Lesion Localization Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies breast lesion localization companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the breast lesion localization companies profiled in this report include-
GE Healthcare
Dragerwerk
Koninklijke Philips
Ambu AS
Medline Industrie
Breast Lesion Localization Market Insights
Lucintel forecasts that breast conservation is expected to witness the higher growth over the forecast period due to the increased detection of early-stage breast cancer and the trend toward less invasive methods.
APAC is expected to witness highest growth over the forecast period due to growing number of hospitals and rising healthcare expenditure, a large increase in patient volume, and a need for healthcare services.
Features of the Global Breast Lesion Localization Market
Market Size Estimates: Breast lesion localization market size estimation in terms of value ($M).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Breast lesion localization market size by type, usage, end use, and region in terms of value ($M).
Regional Analysis: Breast lesion localization market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different type, usage, end use, and regions for the breast lesion localization market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the breast lesion localization market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q1. What is the breast lesion localization market size?
Answer: The global breast lesion localization market is expected to reach an estimated $453 million by 2030.
Q2. What is the growth forecast for breast lesion localization market?
Answer: The global breast lesion localization market is expected to grow with a CAGR of 7.1% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the breast lesion localization market?
Answer: The major drivers for this market are increased knowledge of early breast cancer detection, rise in the number of breast cancer surgeries, as well as, growing need for accurate and minimally invasive surgeries.
Q4. What are the major segments for breast lesion localization market?
Answer: The future of the global breast lesion localization market looks promising with opportunities in the hospital & clinic, diagnostic imaging center, and ambulatory surgical center markets.
Q5. Who are the key breast lesion localization market companies?
Answer: Some of the key breast lesion localization companies are as follows.
GE Healthcare
Dragerwerk
Koninklijke Philips
Ambu AS
Medline Industrie
Q6. Which breast lesion localization market segment will be the largest in future?
Answer: Lucintel forecasts that breast conservation is expected to witness the higher growth over the forecast period due to the increased detection of early-stage breast cancer and the trend toward less invasive methods.
Q7. In breast lesion localization market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness highest growth over the forecast period due to growing number of hospitals and rising healthcare expenditure, a large increase in patient volume, and a need for healthcare services.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the breast lesion localization market by type (wire localization, radioisotope localization, magnetic localization, electromagnetic localization, and others), usage (breast biopsy and breast conservation), end use (hospitals & clinics, diagnostic imaging centers, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
Table of Contents
1. Executive Summary
2. Global Breast Lesion Localization Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Breast Lesion Localization Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Breast Lesion Localization Market by Type
3.3.1: Wire Localization
3.3.2: Radioisotope Localization
3.3.3: Magnetic Localization
3.3.4: Electromagnetic Localization
3.3.5: Others
3.4: Global Breast Lesion Localization Market by Usage
3.4.1: Breast Biopsy
3.4.2: Breast Conservation
3.5: Global Breast Lesion Localization Market by End Use
3.5.1: Hospitals & Clinics
3.5.2: Diagnostic Imaging Centers
3.5.3: Ambulatory Surgical Centers
3.5.4: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Breast Lesion Localization Market by Region
4.2: North American Breast Lesion Localization Market
4.2.1: North American Breast Lesion Localization Market by Usage: Breast Biopsy and Breast Conservation
4.2.2: North American Breast Lesion Localization Market by End Use: Hospitals & Clinics, Diagnostic Imaging Centers, Ambulatory Surgical Centers, and Others
4.3: European Breast Lesion Localization Market
4.3.1: European Breast Lesion Localization Market by Usage: Breast Biopsy and Breast Conservation
4.3.2: European Breast Lesion Localization Market by End Use: Hospitals & Clinics, Diagnostic Imaging Centers, Ambulatory Surgical Centers, and Others
4.4: APAC Breast Lesion Localization Market
4.4.1: APAC Breast Lesion Localization Market by Usage: Breast Biopsy and Breast Conservation
4.4.2: APAC Breast Lesion Localization Market by End Use: Hospitals & Clinics, Diagnostic Imaging Centers, Ambulatory Surgical Centers, and Others
4.5: ROW Breast Lesion Localization Market
4.5.1: ROW Breast Lesion Localization Market by Usage: Breast Biopsy and Breast Conservation
4.5.2: ROW Breast Lesion Localization Market by End Use: Hospitals & Clinics, Diagnostic Imaging Centers, Ambulatory Surgical Centers, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter's Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Breast Lesion Localization Market by Type
6.1.2: Growth Opportunities for the Global Breast Lesion Localization Market by Usage
6.1.3: Growth Opportunities for the Global Breast Lesion Localization Market by End Use
6.1.4: Growth Opportunities for the Global Breast Lesion Localization Market by Region
6.2: Emerging Trends in the Global Breast Lesion Localization Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Breast Lesion Localization Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Breast Lesion Localization Market
